These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8501181)

  • 1. Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.
    Friedman AJ
    Hum Reprod; 1993 Apr; 8(4):540-2. PubMed ID: 8501181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report.
    Thorp JM; Katz VL
    J Reprod Med; 1991 Aug; 36(8):625-6. PubMed ID: 1941808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F; Repinto A; Andreoli C
    Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
    Friedman AJ
    Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complication of triptorelin treatment for uterine myomas.
    Ellenbogen A; Shulman A; Libal Y; Jaschevatzky O; Anderman S; Grunstein S
    Lancet; 1989 Jul; 2(8655):167-8. PubMed ID: 2567943
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
    van Leusden HA
    Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
    [No Abstract]   [Full Text] [Related]  

  • 9. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM; Chou CY; Huang SC; Lin HC
    BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GnRH analogues in the management of uterine leiomyoma].
    Matsuo H; Maruo T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():75-9. PubMed ID: 16689288
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Friedman AJ
    Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
    Filicori M; Hall DA; Loughlin JS; Rivier J; Vale W; Crowley WF
    Am J Obstet Gynecol; 1983 Nov; 147(6):726-7. PubMed ID: 6356927
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report.
    Nelson JR; Corson SL
    Fertil Steril; 1993 Feb; 59(2):441-3. PubMed ID: 8425643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Laparoscopic Myomectomy in Large Myomas With and Without Leuprolide Acetate.
    Chang WC; Chu LH; Huang PS; Huang SC; Sheu BC
    J Minim Invasive Gynecol; 2015; 22(6):992-6. PubMed ID: 25958038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
    George M; Lhomme C; Lefort J; Gras C; Comaru-Schally AM; Schally AV
    Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.